Xanthones explore the mechanism of p53/p21 signaling pathway to prevent cardiac aging and epigenetic regulation of Nrf2 gene
Yuxin Wei,
No information about this author
Yanyan Wang,
No information about this author
Xuebing Jiang
No information about this author
et al.
Archives of Gerontology and Geriatrics,
Journal Year:
2025,
Volume and Issue:
131, P. 105759 - 105759
Published: Jan. 13, 2025
Language: Английский
Comparative Study of Ginsenoside Rg2, 20(S)-Protopanaxatriol, and Afg from Ginseng on Aging-Related Kidney Injury in Samp8 Mice
Published: Jan. 1, 2025
Language: Английский
Ginseng in Delaying Brain Aging: Progress and perspectives
Phytomedicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 156587 - 156587
Published: March 1, 2025
Language: Английский
Comparative Study of Ginsenoside Rg2, 20(S)-protopanaxatriol, and AFG from Ginseng on Aging-related Kidney Injury in SAMP8 Mice
Journal of Ethnopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119807 - 119807
Published: April 1, 2025
Language: Английский
Eight new triterpenoid saponins from the leaves of Astragalus membranaceus (Fisch.) Bunge and their neuroprotective effects
Wen-xiang Xu,
No information about this author
Zhen-yun Liu,
No information about this author
Qing‐Zhou Bu
No information about this author
et al.
Fitoterapia,
Journal Year:
2025,
Volume and Issue:
183, P. 106559 - 106559
Published: April 19, 2025
Language: Английский
AFG, an important maillard reaction product in red ginseng, alleviates D-galactose-induced brain aging in mice via correcting mitochondrial dysfunction induced by ROS accumulation
Junjie Zhang,
No information about this author
Ke‐cheng Chen,
No information about this author
Ji-ying Yin
No information about this author
et al.
European Journal of Pharmacology,
Journal Year:
2023,
Volume and Issue:
952, P. 175824 - 175824
Published: May 31, 2023
Language: Английский
Argininyl-fructosyl-glucose (AFG) antagonizes D-galactose-induced cellular senescence of neuro-2a via inhibiting endoplasmic reticulum stress and apoptosis
Shan Tang,
No information about this author
Yun‐yi Hou,
No information about this author
Rui‐yi Hu
No information about this author
et al.
Journal of Functional Foods,
Journal Year:
2024,
Volume and Issue:
115, P. 106102 - 106102
Published: March 5, 2024
Argininyl-fructosyl-glucose
(AFG),
a
distinctive
non-saponin
compound
isolated
from
red
ginseng
(Panax
ginseng.
C.A.
Meyer),
demonstrates
neuroprotective
effects.
However,
the
molecular
mechanism
underlying
AFG's
anti-aging
properties
remains
unclear.
This
study
established
an
in
vitro
D-galactose-induced
N2a
cells
subacute
aging
model
to
investigate
activity
and
potential
mechanisms.
Results
indicated
that
AFG
treatment
(8
μM)
significantly
reduces
overexpression
of
aging-related
proteins
(p53/p21/p16)
induced
by
D-galactose,
highlighting
its
efficacy.
concurrently
diminishes
ROS
accumulation,
lowering
extracellular
lactate
dehydrogenase
alleviating
intracellular
oxidative
stress.
Notably,
suppresses
PERK/CHOP/caspase
12
pathway,
reducing
Ca2+
concentration
mitigating
endoplasmic
reticulum
(ER)
Additionally,
decreases
Bax
caspase
3
expression,
elevates
Bcl-2
mitochondrial
membrane
potential,
apoptosis.
NAC
with
4-PBA
validated
results.
Overall,
protects
ER
stress
apoptosis,
suggesting
as
key
substance
for
treating
neurodegenerative
diseases.
Language: Английский
Network Pharmacology and Transcriptomics to Explore the Pharmacological Mechanisms of 20(S)-Protopanaxatriol in the Treatment of Depression
Xiangjuan Guo,
No information about this author
Lili Su,
No information about this author
Meiling Shi
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(14), P. 7574 - 7574
Published: July 10, 2024
Depression
is
one
of
the
most
common
psychological
disorders
nowadays.
Studies
have
shown
that
20(S)-protopanaxatriol
(PPT)
can
effectively
improve
depressive
symptoms
in
mice.
However,
its
mechanism
needs
to
be
further
explored.
In
this
study,
we
used
an
integrated
approach
combining
network
pharmacology
and
transcriptomics
explore
potential
mechanisms
PPT
for
depression.
First,
targets
pathways
treatment
depression
were
screened
through
pharmacology.
Secondly,
BMKCloud
platform
was
obtain
brain
tissue
transcription
data
chronic
unpredictable
mild
stress
(CUMS)
model
mice
screen
PPT-altered
differential
expression
genes
(DEGs).
Gene
ontology
(GO)
analysis
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
performed
using
transcriptomics.
Finally,
above
results
verified
by
molecular
docking,
Western
blotting,
quantitative
real-time
polymerase
chain
reaction
(qRT-PCR).
demonstrated
improved
depression-like
behavior
histopathological
changes
CUMS
mice,
downregulated
nitric
oxide
(NO)
interleukin-6
(IL-6)
levels,
elevated
serum
levels
5-hydroxytryptamine
(5-HT)
brain-derived
neurotrophic
factor
(BDNF)
after
compared
group.
Eighty-seven
350
DEGs
identified
Comprehensive
showed
transthyretin
(TTR),
klotho
(KL),
FOS,
phosphatidylinositol
3-kinase–protein
kinase
B
(PI3K-AKT)
signaling
pathway
closely
associated
with
therapeutic
effects
PPT.
Molecular
docking
had
a
high
affinity
PI3K,
AKT,
TTR,
KL,
FOS
targets.
protein
level
could
increase
phosphorylation
PI3K
(p-PI3K),
AKT
(p-AKT),
KL
inhibit
depressed
Our
suggest
may
achieve
inhibiting
enhancing
TTR
modulating
PI3K-AKT
pathway.
Language: Английский